Evaluation of nonmalignant liver masses

Current Gastroenterology Reports

Volumn 8, Issue 1, 2006, Pages 38-45

  Blonski, Wojciech ^b   Reddy, K Rajender ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; CAROLI DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HAMARTOMA; HISTOPATHOLOGY; HUMAN; HYDATID CYST; INTERMETHOD COMPARISON; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CYST; LIVER HEMANGIOMA; LIVER POLYCYSTIC DISEASE; LIVER TUMOR; METASTASIS; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PSEUDOCYST; RELAPSING POLYCHONDRITIS; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

ADENOMA, LIVER CELL; CYSTS; FOCAL NODULAR HYPERPLASIA; HEMANGIOMA, CAVERNOUS; HUMANS; HYPERPLASIA; LIVER; LIVER DISEASES; LIVER NEOPLASMS;

EID: 33645080449     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-006-0062-0     Document Type: Review

References (81)

1. Choi BY, Nguyen MH: The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 2005, 39:401-412.
2. Mortele KJ, Ros PR: Benign liver neoplasms. Clin Liver Dis 2002, 6:119-145.
3. de Rave S, Hussain SM: A liver tumour as an incidental finding: differential diagnosis and treatment. Scand J Gastroenterol Suppl 2002:81-86.
4. Trotter JF, Everson GT: Benign focal lesions of the liver. Clin Liver Dis 2001, 5:17-42, v.
5. Semelka RC, Sofka CM: Hepatic hemangiomas. Magn Reson Imaging Clin N Am 1997, 5(2):241-53.
6. Yoon SS, Charny CK, Fong Y, et al.: Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003, 197:392-402.
7. Harvey CJ, Albrecht T: Ultrasound of focal liver lesions. Eur Radiol 2001, 11:1578-1593.
8. Mergo PJ, Ros PR: Benign lesions of the liver. Radiol Clin North Am 1998, 36:319-331.
9. Karnam U, Reddy K: Approach to the patient with a liver mass. In Textbook of Gastroenterology, edn 4. Edited by Yamada T. Philadelphia: Lippincott Williams & Wilkins, 2003:973-982.
10. Adam YG, Huvos AC, Fortner JG: Giant hemangiomas of the liver. Ann Surg 1970, 172:239-245.
11. Vilgrain V, Boulos L, Vullierme MP, et al.: Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 2000, 20:379-397.
12. Hosten N, Puls R, Bechstein WO, Felix R: Focal liver lesions: Doppler ultrasound. Eur Radiol 1999, 9:428-435.
13. Quaia E, Calliada F, Bertolotto M, et al.: Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004, 232:420-430.
14. Quaia E, Bertolotto M, Dalla Palma L: Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol 2002, 12:537-544.
15. Bartolotta TV, Midiri M, Quaia E, et al.: Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 2005, 15:1643-1649.
16. Hanafusa K, Ohashi I, Himeno Y, et al.: Hepatic hemangioma: findings with two-phase CT. Radiology 1995, 196:465-469.
17. Leslie DF, Johnson CD, MacCarty RL, et al.: Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. AJR Am J Roentgenol 1995, 165:1403-1406.
18. Leslie DF, Johnson CD, Johnson CM, et al.: Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. AJR Am J Roentgenol 1995, 164:625-629.
19. Nino-Murcia M, Olcott EW, Jeffrey RB, Jr, et al.: Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology 2000, 215:746-751.
20. Yun EJ, Choi BI, Han JK, et al.: Hepatic hemangioma: contrast-enhancement pattern during the arterial and portal venous phases of spiral CT. Abdom Imaging 1999, 24:262-266.
21. Kim T, Federle MP, Baron RL, et al.: Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 2001, 219:699-706.
22. Brunt EM: Benign tumors of the liver. Clin Liver Dis 2001, 5:1-15, v.
23. Op de Beeck B, Luypaert R, Dujardin M, Osteaux M: Benign liver lesions: differentiation by magnetic resonance. Eur J Radiol 1999, 32:52-60.
24. Numminen K, Halavaara J, Tervahartiala P. et al.: Liver tumour MRI: what do we need for lesion characterization? Scand J Gastroenterol 2004, 39:67-73.
25. Buscarini E, Danesino C, Plauchu H, et al.: High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 2004, 30:1089-1097.
26. Nguyen BN, Flejou JF, Terris B, et al.: Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999, 23:1441-1454.
27. Luciani A, Kobeiter H, Maison P, et al.: Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut 2002, 50:877-880.
28. Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985, 5:1194-1200.
29. Mathieu D, Kobeiter H, Maison P, et al.: Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000, 118:560-564.
30. Scalori A, Tavani A, Gallus S, et al.: Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol 2002, 186:195-197.
31. Leconte I, Van Beers BE, Lacrosse M, et al.: Focal nodular hyperplasia: natural course observed with CT and MRI. J Comput Assist Tomogr 2000, 24:61-66.
32. Ishak KG, Rabin L: Benign tumors of the liver. Med Clin North Am 1975, 59:995-1013.
33. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995, 22:983-993.
34. Hussain SM, Terkivatan T, Zondervan PE, et al.: Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004, 24:3-17, discussion 8-9.
35. Kehagias D, Moulopoulos L, Antoniou A, et al.: Focal nodular hyperplasia: imaging findings. Eur Radiol 2001, 11:202-212.
36. Uggowitzer MM, Kugler C, Mischinger HJ, et al.: Echoenhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med 1999, 18:445-451, quiz 53-54.
37. Brancatelli G, Federle MP, Grazioli L, et al.: Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001, 219:61-68.
38. Choi CS, Freeny PC: Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. AJR Am J Roentgenol 1998, 170:391-395.
39. Carlson SK, Johnson CD, Bender CE, Welch TJ: CT of focal nodular hyperplasia of the liver. AJR Am J Roentgenol 2000, 174:705-712.
40. Edmondson HA, Henderson B, Benton B: Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976, 294:470-472.
41. Mattison GR, Glazer GM, Quint LE, et al.: MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors. AJR Am J Roentgenol 1987, 148:711-715.
42. Mathieu D, Rahmouni A, Anglade MC, et al.: Focal nodular hyperplasia of the liver: assessment with contrast-enhanced TurboFLASH MR imaging. Radiology 1991, 180:25-30.
43. Baum JK, Bookstein JJ, Holtz F, Klein EW: Possible association between benign hepatomas and oral contraceptives. Lancet 1973, 2:926-929.
44. Rooks JB, Ory HW, Ishak KG, et al.: Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979, 242:644-648.
45. Labrune P, Trioche P, Duvaltier I, et al.: Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997, 24:276-279.
46. Carrasco D, Prieto M, Pallardo L, et al.: Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature. J Hepatol 1985, 1:573-578.
47. Kerlin P, Davis GL, McGill DB, et al.: Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983, 84:994-1002.
48. Foster JH, Berman MM: The malignant transformation of liver cell adenomas. Arch Surg 1994, 129:712-717.
49. De Carlis L, Pirotta V, Rondinara GE, et al.: Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 1997, 3:160-165.
50. Terkivatan T, de Wilt JH, de Man RA, et al.: Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001, 136:1033-1038.
51. Reddy KR, Kligerman S, Levi J, et al.: Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001, 67:173-178.
52. Charny CK, Jarnagin WR, Schwartz LH, et al.: Management of 155 patients with benign liver tumours. Br J Surg 2001, 88:808-813.
53. Hung CH, Changchien CS, Lu SN, et al.: Sonographic features of hepatic adenomas with pathologic correlation. Abdom Imaging 2001, 26:500-506.
54. Ichikawa T, Federle MP, Grazioli L, Nalesnik M: Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000, 214:861-868.
55. Grazioli L, Federle MP, Brancatelli G, et al.: Hepatic adenomas: imaging and pathologic findings. Radiographics 2001, 21:877-892, discussion 92-94.
56. Flejou JF, Barge J, Menu Y, et al.: Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985, 89:1132-1138.
57. Grazioli L, Federle MP, Ichikawa T, et al.: Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000, 216:395-402.
58. Buchel O, Roskams T, Van Damme B, et al.: Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia. Gut 2005, 54:1021-1023.
59. Naber AH, Van Haelst U, Yap SH: Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991, 12:94-99.
60. Nakanuma Y: Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gstroenterol 1990, 12:460-465.
61. Casillas C, Marti-Bonmati L, Galant I: Pseudotumoral presentation of nodular regenerative hyperplasia of the liver: imaging in five patients including MR imaging. Eur Radiol 1997, 7:654-658.
62. Rha SE, Lee MG, Lee YS, et al.: Nodular regenerative hyperplasia of the liver in Budd-Chiari syndrome: CT and MR features. Abdom Imaging 2000, 25:255-258.
63. Taylor BR, Langer B: Current surgical management of hepatic cyst disease. Adv Surg 1997, 31:127-148.
64. Cowles RA, Mulholland MW: Solitary hepatic cysts. J Am Coll Surg 2000, 191:311-321.
65. Federle MP, Brancatelli C: Imaging of benign hepatic masses. Semin Liver Dis 2001, 21:237-249.
66. Gaines PA, Sampson MA: The prevalence and characterization of simple hepatic cysts by ultrasound examination. Br J Radiol 1989, 62:335-337.
67. Caremani M, Vincenti A, Benci A, et al.: Ecographic epidemiology of non-parasitic hepatic cysts. J Clin Ultrasound 1993, 21:115-118.
68. Regev A, Reddy KR, Berho M, et al.: Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center. J Am Coll Surg 2001, 193:36-45.
69. vanSonnenberg E, Wroblicka JT, D'Agostino HB, et al.: Symptomatic hepatic cysts: percutaneous drainage and sclerosis. Radiology 1994, 190:387-392.
70. Tchelepi H, Ralls PW: Ultrasound of focal liver masses. Ultrasound Q 2004, 20:155-169.
71. Nisenbaum HL, Rowling SE: Ultrasound of focal hepatic lesions. Semin Roentgenol 1995, 30:324-346.
72. Fulcher AS, Sterling RK: Hepatic neoplasms: computed tomography and magnetic resonance features. J Clin Gastroenterol 2002, 34:463-471.
73. Mortele KJ, Ros PR: Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 2001, 21:895-910.
74. Alobaidi M, Shirkhoda A: Benign focal liver lesions: discrimination from malignant mimickers. Curr Probl Diagn Radiol 2004, 33:239-253.
75. Horton KM, Bluemke DA, Hruban RH, et al.: CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999, 19:431-451.
76. Karnam U, Reddy KR: Approach to the patient with a liver mass. In Atlas of Gastroenterology, edn 3. Edited by Yamada T. Philadelphia: Lippincott Williams & Wilkins, 2003:111-117.
77. Desmet VJ: Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation". Hepatology 1992, 16:1069-1083.
78. Levy AD, Rohrmann CA, Jr, Murakata LA, Lonergan GJ: Caroli's disease: radiologic spectrum with pathologic Correlation. AJR Am J Roentgenol 2002, 179:1053-1057.
79. Choi BI, Yeon KM, Kim SH, Han MC: Caroli disease: central dot sign in CT. Radiology 1990, 174:161-163.
80. Pavone P, Laghi A, Catalano C, et al.: Caroli's disease: evaluation with MR cholangiopancreatography (MRCP). Abdom Imaging 1996, 21:117-119.
81. Torzilli G, Minagawa M, Takayama T, et al.: Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999, 30:889-893.